Approaches to Improve the Immunogenicity of Plasmid DNA-Based Vaccines against COVID-19
Plasmid DNA-based vaccines are attracting considerable interest because of their potential as a platform technology that can be used for a variety of purposes from prevention to therapy. The COVID-19 pandemic has stimulated the development of this platform. The DNA vaccine against COVID-19, develope...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/88789 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Approaches to Improve the Immunogenicity of Plasmid DNA-Based Vaccines against COVID-19
- Scalable Technology to Produce Pharmaceutical Grade Plasmid DNA for Gene Therapy
- A Review of COVID-19 Vaccines, Immunogenicity, Safety, and Efficacy toward Addressing Vaccine Hesitancy, Inequity, and Future Epidemic Preparedness
- Immunogenicity Prediction with Dual Attention Enables Vaccine Target Selection
- Plasmid biopharmaceuticals basics, applications, and manufacturing /
- The Development of Oral Therapeutic Vaccine against Cancer and Working out on the Fast Testing of Immunogenic and Oncolytic Effector Antigens
- Immunogenicity Study of Biosimilar Candidates